Since these various roles of RAD51 in DNA damage are closely related to genome stability, the normal cell cycle, and immunity, RAD51 has been considered a promising therapeutic target for various cancers including lung, breast, melanoma, and pancreatic cancer [7,8,9,10,11]. The gene discussed is RAD51; the disease is familial pancreatic carcinoma.